In this episode of the Eye Believe Podcast, we’re joined by Dr. Hadfield, a medical oncologist treating uveal melanoma patients in the Northeast, for an in-depth discussion of the most important takeaways from ESMO 2025.

Dr. Hadfield breaks down key study results and emerging data from major trials, including the CHOPIN Trial, Immatics Trial, IDEAYA Trial, and more—offering expert insight into what these findings may mean for patients, caregivers, and the future of uveal melanoma treatment.

Links mentioned in this episode

Q1 Eye on the Experts Webinar: Eyes on the Chopin Study: What does this mean for patients? https://events.zoom.us/ev/AgpsCnGSA4Hnib_afWXvh5jNq0qqSTvpKhOB8xHg0M9cItAlsoSw~Ah8MbImmpM---YQJIycJ2xa5cdZV0t5y8JSYZGuk2DnZJoO6vsGncOFduA

ACIS Physician Finder: https://acureinsight.org/resources/ - click physician finder

ACIS Metastatic Treatment Resources (including the July 2025 updated clinical trial summaries of enrolling trials): https://acureinsight.org/metastatic-om/

ASCO Fiber Study 2025: https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.9511

Summary of Studies discussed from attendance at ESMO: (https://acureinsight.org/acis-summary-of-uveal-melanoma-um-presentations-abstracts-and-posters-at-the-annual-meeting-of-the-european-society-for-medical-oncology-esmo-october-17-21-2025-berlin-germany/

ACIS NEWS RELEASES: follow along and subscribe to our newsletter to see the latest updates as we have them. https://acureinsight.org/ocular-melanoma-news/

Whether you’re a patient, advocate, or clinician, this episode provides a clear and accessible overview of the latest research shaping the uveal melanoma landscape.

Tune in to learn what’s new, what’s promising, and where the field may be headed next.